Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parsons Research Center for Psychedelic Healing is a specialized clinical research and therapeutic organization focused on the advancement of psychedelic-assisted therapies. The center conducts clinical trials and provides integrative mental health services utilizing substances such as psilocybin, MDMA, and ketamine to treat refractory psychiatric conditions. By combining pharmacological intervention with structured psychotherapy, the center aims to establish standardized protocols for psychedelic medicine. Their work primarily targets treatment-resistant depression and post-traumatic stress disorder through rigorous clinical evaluation and patient-centered care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parsons Research Center for Psychedelic Healing.